Clinical Trial: Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Non Interventional Study in Slovak Patients With Primary Open Angle Glaucoma and/or Ocular Hypertension Treated With Xalacom® After Failure of Previous Antiglaucoma T
Brief Summary: This study is designed to evaluate the safety and tolerability of Xalacom in patients with primary glaucoma
Detailed Summary: according to physicians decision, patients who met inclusion and exclusion criteria and sign the ICD
Sponsor: Pfizer
Current Primary Outcome:
- Incidence of ocular hyperemia [ Time Frame: 12 months ]
- safety of treatment [ Time Frame: 12 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome: effectiveness in IOP lowering [ Time Frame: 12 months ]
Original Secondary Outcome: Same as current
Information By: Pfizer
Dates:
Date Received: November 19, 2008
Date Started: October 2008
Date Completion:
Last Updated: June 28, 2011
Last Verified: June 2011
